Codiak BioSciences (CDAK) director Cooney acquired 8,750 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Charles L Cooney (director at Codiak BioSciences Inc., CDAK) reported that they acquired 8,750 shares on Feb 16, 2023. After these transactions the filing shows 8,750 shares held directly.
- Reporting person
- Cooney Charles L
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +8,750 | - | - | 8,750 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2023 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 8,750 Common Stock2, 3 | -8,750 | - | - | 0 direct |
Holdings before and after
- Common Stock: 0 to 8,750 direct
- Restricted Stock Units: 8,750 to 0 direct
Footnotes from the filing
- 1. Restricted stock units ( RSUs ) convert into common stock on a one-for-one basis.
- 2. Each RSU represents a contingent right to receive one share of common stock.
- 3. On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Cooney report in this CDAK Form 4?
Charles L Cooney (director at Codiak BioSciences Inc., CDAK) reported that they acquired 8,750 shares on Feb 16, 2023. After these transactions the filing shows 8,750 shares held directly.
How many CDAK shares does Cooney hold after this filing?
The filing shows 8,750 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for CDAK
Earlier insider filings at CDAK
- Feb 21, 2023SEC Form 4: Melas Kyriazi Theo converted options into 8,750 shares, increasing direct ownership by 133% to 15,350 units
- Feb 21, 2023SEC Form 4: Howze Yalonda converted options into 9,713 shares and sold $4,297 worth of shares (3,115 units at $1.38), increasing direct ownership by 265% to 9,086 units to satisfy withholding obligation
- Jan 26, 2023SEC Form 4 filed by Mauro David J
- Jan 26, 2023SEC Form 4 filed by Konstantinov Konstantin
- Jan 26, 2023SEC Form 4 filed by Sathyanarayanan Sriram
Quantisnow market dataNASDAQ
CDAK
Codiak BioSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Get push alerts for CDAK
Full CDAK profile on Quantisnow Follow CDAK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time